The Fate Of Biden-Era Clinical Study Guidance Under Trump
Among the flurry of U.S. Food and Drug Administration guidance documents issued in early January by the outgoing Biden Administration were two guidance drafts addressing the study and evaluation of sex...To view the full article, register now.
Already a subscriber? Click here to view full article